HAEMONETICS CORP — Director's Dealing 2023

Sep 13, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2023-09-12

Reporting Person: Strong Stewart W (President, Global Hospital)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-12	Common Stock	S	228	$90.65	Disposed	16221	Direct

Footnotes

F1: Transaction pursuant to an existing 10b5-1 trading plan dated June 12, 2023 (fully executed as of June 12, 2023).

F2: This number includes unvested restricted stock units previously reported.